Integrative Therapeutics Berberine | Metabolic Support

Integrative Therapeutics Berberine is a metabolic support supplement designed to promote healthy glucose and lipid metabolism. Each capsule delivers Berberine, one of the most extensively studied botanical compounds in natural products pharmacology, to help maintain blood sugar and insulin levels already within a normal range.

At the center of Berberine's metabolic activity is its ability to activate adenosine monophosphate-activated protein kinase (AMPK), a central regulator of cellular energy homeostasis. AMPK activation stimulates catabolic processes such as fatty acid oxidation and glucose uptake while inhibiting anabolic processes like gluconeogenesis and cholesterol synthesis, making Integrative Therapeutics Berberine a targeted choice for individuals seeking comprehensive metabolic support.

This formula is gluten-free, vegan, and free from wheat, soy, corn, dairy, artificial colors, flavors, and preservatives. Each bottle contains 60 capsules, and the product is bottled and tested in the USA.

Berberine's metabolic effects stem from multiple interconnected mechanisms. Its activation of AMPK is a primary pathway: studies in human hepatoma cells have shown that Berberine inhibits cholesterol and triglyceride synthesis, with significant increases in AMPK phosphorylation and subsequent fatty acid oxidation. This mirrors the activity of pharmaceutical AMPK activators.

Beyond AMPK, Berberine significantly increases hepatic low-density lipoprotein receptor (LDLR) expression and reduces the expression and secretion of PCSK9, a protein that degrades LDL receptors. By upregulating LDLR through the AMPK/Raf-1/MEK/ERK signaling cascade, Berberine helps the liver clear more LDL cholesterol from the bloodstream.

Research also suggests that Berberine supports glucose-stimulated insulin secretion. A randomized, double-blind, placebo-controlled phase 1 clinical trial demonstrated that Berberine enhances glucose-stimulated insulin secretion in humans without altering basal insulin levels, meaning its glucose-lowering effect is high-glucose-dependent.

Emerging research highlights Berberine's ability to modulate the gut microbiota, reshaping microbial populations in ways that may reduce bacterial colonization-related inflammation and elevate short-chain fatty acid (SCFA) levels in the intestine — further connecting gut health to systemic metabolic function.

Integrative Therapeutics Berberine is formulated for adults looking to support healthy metabolic function. It may be particularly relevant for individuals seeking to maintain blood sugar and insulin levels already within a normal range, or those interested in supporting healthy lipid metabolism, including cholesterol and triglyceride levels.

Research suggests Berberine may also support individuals working on body composition goals, as meta-analyses have documented modest reductions in body weight, BMI, and waist circumference when used as an adjunct to a healthy lifestyle. Its role in supporting cardiovascular risk factors — including LDL-C, total cholesterol, triglycerides, and systolic blood pressure — makes it relevant for those focused on heart health.

People who are pregnant or breastfeeding should not use Berberine, and it should not be given to infants. Because Berberine inhibits CYP3A4, CYP2D6, and CYP2C9 enzymes, individuals taking prescription medications — particularly statins, blood thinners such as warfarin, immunosuppressants like cyclosporine, or antidiabetic medications — should consult a healthcare professional before use.

Adults take 1 capsule two to three times daily, or as recommended by a healthcare professional.

Each capsule provides a single serving. The 60-capsule bottle supports a usage period of approximately 20 to 30 days depending on the number of daily servings. Clinical trials have most commonly studied Berberine at doses of 500 mg administered two to three times per day, aligning with this product's suggested use.